VBSVECTUS BIOSYSTEMS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 July 2026, 04:25 | Cleansing Notice | Securities Administration | — | 06018 | |
| 30 July 2026, 04:21 | Application for quotation of securities - VBS | Other | — | 06020 | |
| 29 July 2026, 03:58 | Quarterly Activities & Appendix 4C Cash Flow Reports | Quarterly Reports | MS | 19004, 19009 | |
| 13 July 2026, 19:53 | VBS Engages CHRS as Regulatory Agent for FDA Submissions | Company Update | — | 11001 | |
| 27 June 2026, 02:19 | Cleansing Notice | Securities Administration | — | 06018 | |
| 27 June 2026, 02:14 | Application for quotation of securities - VBS | Other | — | 06020 | |
| 17 June 2026, 18:17 | CEO Investor Webinar | Presentations | — | 12008, 14014 | |
| 30 May 2026, 03:17 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 28 May 2026, 19:57 | Change in substantial holding KHPL | Substantial Holders | — | 02002 | |
| 28 May 2026, 05:15 | Cleansing Notice | Securities Administration | — | 06018 | |
| 27 May 2026, 21:56 | Application for quotation of securities - VBS | Other | — | 06020 | |
| 23 May 2026, 03:03 | Proposed issue of securities - VBS | Securities Administration | — | 06013 | |
| 23 May 2026, 01:18 | Placement of Shares | Capital Raising | MS | 06003 | |
| 15 May 2026, 18:20 | Updated Corporate Presentation | Presentations | — | 03026 | |
| 13 May 2026, 03:26 | Cleansing Notice | Securities Administration | — | 06018 | |
| 13 May 2026, 03:21 | Application for quotation of securities - VBS | Other | — | 06020 | |
| 9 May 2026, 01:33 | Cleansing Notice | Securities Administration | — | 06018 | |
| 9 May 2026, 01:29 | Application for quotation of securities - VBS | Other | — | 06020 | |
| 9 May 2026, 01:25 | Notification regarding unquoted securities - VBS | Other | — | 06021 | |
| 8 May 2026, 03:09 | Appointment of Dr Tara Speranza as CEO & CTO | Company Administration | MS | 12008, 12019 | |
| 1 May 2026, 01:10 | Quarterly Activities & Appendix 4C Cash Flow Reports | Quarterly Reports | MS | 19003, 19008 | |
| 14 Apr 2026, 18:12 | VB4-P5 Renal Compound Transaction Settled | Company Update | MS | 11001 | |
| 26 Feb 2026, 23:25 | Half Year Report & Appendix 4D | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 31 Jan 2026, 01:49 | Quarterly Activities & Appendix 4C Cash Flow Reports | Quarterly Reports | MS | 19002, 19007 | |
| 23 Dec 2025, 23:39 | Cleansing Notice | Securities Administration | — | 06018 | |
| 23 Dec 2025, 23:35 | Application for quotation of securities - VBS | Other | — | 06020 | |
| 5 Dec 2025, 02:14 | Cleansing Notice | Securities Administration | — | 06018 | |
| 5 Dec 2025, 02:03 | Application for quotation of securities - VBS | Other | — | 06020 | |
| 27 Nov 2025, 03:25 | Results of 2025 AGM | Meetings & Governance | — | 08003 | |
| 26 Nov 2025, 23:04 | 2025 AGM Presentations | Presentations | — | 03026, 15002 | |
| 12 Nov 2025, 02:51 | Response to ASX Query Letter | ASX Query | MS | 17003 | |
| 31 Oct 2025, 05:28 | Quarterly Activities & Appendix 4C Cash Flow Reports | Quarterly Reports | MS | 19001, 19006 | |
| 25 Oct 2025, 03:14 | Notice of 2025 Annual General Meeting & Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 18 Oct 2025, 05:37 | Reinstatement to Quotation | Reinstatement | MS | 09002 | |
| 18 Oct 2025, 05:37 | VB4-P5 Renal Compound Transaction | Company Update | MS | 11001 | |
| 17 Oct 2025, 23:12 | Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 16 Oct 2025, 01:44 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 16 Oct 2025, 00:11 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 9 Oct 2025, 22:17 | Date of 2025 Annual General Meeting | Meetings & Governance | — | 08006 | |
| 29 Sept 2025, 22:54 | 2025 Corporate Governance Statement & Appendix 4G | Company Administration | — | 03024, 03025 | |
| 29 Sept 2025, 22:45 | Annual Report to shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 30 Aug 2025, 04:32 | Full Year Statutory Accounts | Financial Results | — | 03011, 03012, 03013, 03020 | |
| 30 Aug 2025, 04:28 | Preliminary Final Report | Financial Results | MS | 03003 |
1–43 of 43
1 / 1